CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-19 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase | +10,770 | $0.93 | $10K | 53,095 |
| 2019-09-23 | Parks Diane L. Director | Purchase | +14,940 | $0.93 | $14K | 14,940 |
| 2019-09-19 | ZELDIS JEROME B Director | Purchase | +4,000 | $0.94 | $4K | 20,917 |
| 2019-09-09 | Guarino Jonathan L. Senior Vice President and CFO | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2019-09-06 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +30,928 | 30,928 | ||
| 2019-09-06 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +30,928 | 30,928 | ||
| 2019-09-06 | Pearson Mark E. Director | Grant or award · Stock Option (Right to Buy) | +30,928 | 30,928 | ||
| 2019-09-06 | Parks Diane L. Director | Grant or award · Stock Option (Right to Buy) | +30,928 | 30,928 | ||
| 2019-09-06 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +30,928 | 30,928 | ||
| 2019-07-08 | Parks Diane L. Director | Grant or award · Stock Option (Right to Buy) | +1,500 | 1,500 | ||
| 2019-06-28 | Pearson Mark E. Director | Grant or award | +78,338 | $0.71 | $56K | 78,338 |
| 2019-04-22 | ZELDIS JEROME B Director | Purchase | +10,000 | $0.73 | $7K | 16,917 |
| 2019-04-22 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase | +5,000 | $0.72 | $4K | 42,325 |
| 2019-01-02 | SCHABER CHRISTOPHER J Chairman, CEO and President | Grant or award · Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-12-13 | Straube Richard SVP and CMO | Grant or award · Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-12-13 | SCHABER CHRISTOPHER J Chairman, CEO and President | Grant or award · Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-12-13 | Krumeich Karen R SVP and CFO | Grant or award · Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-12-13 | Donini Oreola SVP and CSO | Grant or award · Option (Right to Buy) | +40,000 | 40,000 | ||
| 2018-10-18 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase | +8,700 | $1.17 | $10K | 37,325 |
| 2018-10-17 | Pearson Mark E. Director | Purchase | +170,000 | $1.16 | $197K | 2,500,000 |
Page 7 of 8 · 141 trades